26 studies found for:    " December 14, 2011":" January 13, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" December 14, 2011":" January 13, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma
Conditions: HIV;   Burkitt's Lymphoma
Interventions: Drug: Induction Phase;   Drug: Consolidation Phase (on day +50);   Drug: Intensification phase;   Drug: BEAM conditioning;   Radiation: Consolidation radiotherapy
2 Active, not recruiting Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/GS-7340 Single Tablet Regimen Versus Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen in HIV 1 Infected, Antiretroviral Treatment-Naive Adults
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: E/C/F/TAF;   Drug: E/C/F/TDF;   Drug: Placebo to match E/C/F/TAF;   Drug: Placebo to match E/C/F/TDF
3 Active, not recruiting Phase 3b Open Label Study to Evaluate Switching From Regimens Consisting of a Non-nucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV 1 Infected Patients
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: Stribild;   Drug: TVD;   Drug: NNRTI
4 Completed Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome
Condition: HIV Lipodystrophy
Interventions: Drug: Human recombinant leptin ("metreleptin");   Drug: Placebo
5 Completed Safety and Immunogenicity Study of HIV-MAG Vaccine +/- IL-12 and Ad35-GRIN/ENV in HIV-uninfected Volunteers
Condition: HIV Infections
Interventions: Biological: HIV-MAG (3,000mcg);   Biological: GENEVAX® IL-12 (100mcg);   Biological: GENEVAX® IL-12 (1000mcg);   Biological: Ad35-GRIN/ENV
6 Active, not recruiting Perinatal Antiretroviral Intensification for PMTCT of HIV in Late Comers
Condition: HIV Infections
Intervention: Drug: Nevirapine, zidovudine, lamivudine
7 Completed Telephone-delivered Behavioral Interventions to Reduce Risky Sexual Behavior in HIV-positive Late Middle-age and Older Adults
Condition: Unsafe Sex
Interventions: Behavioral: 1-session of telephone-administered motivational interviewing;   Behavioral: 4-session telephone-administered motivational interviewing
8 Recruiting Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence
Condition: HIV Infection
Interventions: Drug: Immediate ARV treatment initiation with TDF/FTC/EFV;   Other: South African recommendation guided ARV (TDF/FTC/EFV) initiation
9 Recruiting Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women
Condition: HIV Infection
Interventions: Drug: Maraviroc;   Drug: Emtricitabine;   Drug: Tenofovir disoproxil fumarate;   Other: Maraviroc placebo;   Other: Emtricitabine placebo;   Other: Tenofovir disoproxil fumarate placebo
10 Completed Couple-oriented Prenatal HIV Counseling in Low and Medium HIV Prevalence Countries
Conditions: Partner HIV Testing;   Couple HIV Counseling;   Couple Communication;   HIV Incidence
Intervention: Behavioral: Couple-oriented post-test HIV counseling
11 Active, not recruiting
Has Results
A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive Subjects
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Dolutegravir
12 Completed Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and Ethinylestradiol
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Ortho-Cyclen;   Drug: Dolutegravir;   Drug: Placebo
13 Not yet recruiting Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Isoniazid (INH);   Drug: Placebo for isoniazid (INH)
14 Recruiting Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and Children
Condition: HIV Infections
Intervention: Drug: Etravirine (ETR)
15 Recruiting Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection
Condition: Atherosclerosis
Intervention:
16 Recruiting American Ginseng to Improve HIV-Associated Fatigue: A Randomized, Placebo-Controlled, Parallel Design, Multiple-Dose Clinical Trial
Condition: HIV/AIDS-associated Fatigue
Interventions: Drug: American ginseng;   Dietary Supplement: Placebo for American ginseng
17 Unknown  Randomized Controlled Trial Using Patient Reported Outcomes and Care Managers to Improve HIV Medication Adherence in Routine Clinical Care
Condition: HIV
Intervention: Behavioral: Care management
18 Not yet recruiting Repeat Sexually Transmitted Infection (STI) Patients: Tailored Socio-Contextual Intervention to Reduce HIV Risk
Conditions: Sexually Transmitted Infection;   HIV
Interventions: Behavioral: Tailored Socio-Contextual Intervention;   Behavioral: Standard of Care
19 Unknown  Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults
Conditions: HPV;   HIV
Intervention: Biological: Quadrivalent Human Papillomavirus (6, 11, 16 and 18) vaccine (Gardasil ®)
20 Recruiting A Stage 2 Cognitive-behavioral Trial: Reduce Alcohol First in Kenya Intervention
Conditions: Hazardous Drinking;   Binge Drinking;   HIV-infected
Interventions: Behavioral: cognitive behavioral group therapy;   Behavioral: health education group

Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results
Indicates status has not been verified in more than two years